A longitudinal analysis with CA-125 to predict overall survival in patients with ovarian cancer-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

A longitudinal analysis with CA-125 to predict overall survival in patients with ovarian cancer

Published:2014 Issue:1 Volume:25 Page:51
ISSN:2005-0380
Container-title:Journal of Gynecologic Oncology
language:en
Short-container-title:J Gynecol Oncol

Author:

Chiang An Jen¹²³,Chen Jiabin⁴,Chung Yu-Che⁵,Huang Huan-Jung⁵,Liou Wen Shiung¹,Chang Chung⁵

Affiliation:

1. Department of Obstetrics and Gynecology, Kaohsiung Veterans General Hospital, Kaohsiung, Taiwan, ROC.

2. Department of Biological Sciences, National Sun Yat-sen University, Kaohsiung, Taiwan, ROC.

3. Department of Pharmacy and Graduate Institute of Pharmaceutical Technology, Ta-Jen University, Pingtung, Taiwan, ROC.

4. Multidisciplinary Science Research Center, Taiwan, ROC.

5. Department of Applied Mathematics, National Sun Yat-sen University, Kaohsiung, Taiwan, ROC.

Funder

KSVGH

National Science Council of Taiwan

Publisher

Asian Society of Gynecologic Oncology; Korean Society of Gynecologic Oncology and Colposcopy

Subject

Obstetrics and Gynaecology,Oncology,General Medicine

Link

https://synapse.koreamed.org/pdf/10.3802/jgo.2014.25.1.51

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Dynamic Prediction of Resectability for Patients with Advanced Ovarian Cancer Undergoing Neo-Adjuvant Chemotherapy: Application of Joint Model for Longitudinal CA-125 Levels;Cancers;2022-12-30

2. The Effect of Delayed Chemotherapy on the Decrease of CA125 in Epithelial Ovarian Cancer During Coronavirus Disease Pandemic in 2020;Cancer Management and Research;2021-01

3. The reduction of CA 125 serum levels in BRCA 1/2 mutation carriers after risk-reducing salpingo-oophorectomy is only partially associated with surgery: a prospective cohort, other biomarker controlled, study;European Journal of Cancer Prevention;2020-07

4. CA-125 ELIMination Rate Constant K (KELIM) Is a Marker of Chemosensitivity in Patients with Ovarian Cancer: Results from the Phase II CHIVA Trial;Clinical Cancer Research;2020-03-24

5. Association of expression of p53, livin, ERCC1, BRCA1 and PARP1 in epithelial ovarian cancer tissue with drug resistance and prognosis;Pathology - Research and Practice;2020-02

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3